Page last updated: 2024-09-04

torcetrapib and Hyperglycemia, Postprandial

torcetrapib has been researched along with Hyperglycemia, Postprandial in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briand, F; Costard, C; Muzotte, E; Prunet-Marcassus, B; Sordello, S; Sulpice, T; Thieblemont, Q1
Gore, MO; McGuire, DK1
Wiviott, SD1
Barter, PJ; Boekholdt, SM; Breazna, A; Kastelein, JJ; Rye, KA; Tardif, JC; Waters, DD1

Reviews

1 review(s) available for torcetrapib and Hyperglycemia, Postprandial

ArticleYear
Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs.
    Current cardiology reports, 2009, Volume: 11, Issue:4

    Topics: Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Quinolines; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones

2009

Trials

1 trial(s) available for torcetrapib and Hyperglycemia, Postprandial

ArticleYear
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
    Circulation, 2011, Aug-02, Volume: 124, Issue:5

    Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glycated Hemoglobin; Heptanoic Acids; Homeostasis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Pyrroles; Quinolines

2011

Other Studies

2 other study(ies) available for torcetrapib and Hyperglycemia, Postprandial

ArticleYear
Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters.
    Atherosclerosis, 2014, Volume: 233, Issue:2

    Topics: AMP-Activated Protein Kinases; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins E; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cricetinae; Deoxyglucose; Diet, Atherogenic; Disease Models, Animal; Drug Evaluation, Preclinical; Dyslipidemias; Enzyme Activation; Feces; Glucose; Homeostasis; Hyperglycemia; Insulin Resistance; Male; Mesocricetus; Muscle, Skeletal; Quinolines; Random Allocation; Species Specificity

2014
ILLUMINATE sheds more light.
    Circulation, 2011, Aug-02, Volume: 124, Issue:5

    Topics: Anticholesteremic Agents; Blood Glucose; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Male; Quinolines

2011